A B S T R A C T 18 patients with idiopathic pulmonary fibrosis were studied to determine if they had morphologic evidence of small airways disease and if physiologic testing could predict morphologic findings. In the presence of normal airway function by standard physiologic studies (forced expiratory volume in 1 s/forced vital capacity and airway resistance by plethysmography), dynamic compliance, maximum expiratory flow-volume curves, and maximum flowstatic recoil curves were measured to detect physiologic alterations consistent with small airways abnormalities. These physiologic data were then compared with estimates of small airways diameter made in lung biopsy specimens.
INTRODUCTION
Idiopathic pulmonary fibrosis (IPF)l is a well-defined subgroup of the fibrotic lung disorders, characterized by distinct clinical, radiographic, physiologic, and morphologic features (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . These patients usually have exertional breathlessness, a diffuse interstitial infiltrate on chest X ray, decreased lung volumes, decreased diffusing capacity, and hypoxemia which worsens with exercise. Although the hypoxemia in IPF was initially thought to result from a diffusion barrier to oxygen (17) , current data suggest that it mostly results from a ventilation-perfusion imbalance (18, 19) .
In general, the most likely cause of hypoxemia secondary to a ventilation-perfusion imbalance is maldistribution of ventilation resulting either from airways disease or alterations in regional compliance or both. Because IPF has been considered to be a disease of alveoli and not of airways, maldistribution of ventilation in this disorder has previously been attributed to alterations in regional compliance (18) . However, recent studies in disorders other than IPF (e.g. asthma) ' Abbreviations used in this paper: Cdyn, dynamic compliance; Cstat, static compliance; DLCO, carbon dioxide diffusing capacity; FEV,%, forced expiratory volume in 1 s/forced vital capacity; FRC, functional residual capacity; IPF, idiopathic pulmonary fibrosis; MEFV, maximum expiratory flow volume; MFSR, maximum flow static recoil; PL, transpulmonary pressure; Pst, static transpulmonary pressure; Raw, airway resistance; RV, residual volume; TLC, total lung capacity; VC, vital capacity; Vmax, maximum expiratory flow. TheJournal of Clinical Investigation Volume 60 September 1977-595-610 595
have demonstrated that hypoxemia can result from the maldistribution of ventilation due to narrowing of small (<2 mm) airways, an obstruction which is not detected by standard physiologic studies (20, 21) . In light of these newer concepts of small airways disease, the present study was designed to: (a) evaluate the morphology of small airways in IPF; (b) determine if patients with IPF have physiologic alterations consistent with small airways disease; and (c) attempt to correlate these morphologic and physiologic findings. To do so, we chose a group of patients with IPF who had normal airway function by standard physiologic studies and who had undergone lung biopsy within close proximity to a physiologic evaluation of small airways function. The results demonstrate that we must expand the concepts of IPF to consider it a disorder of small airways as well as alveoli.
METHODS

Patient population
Over an 18-mo period, 150 patients were referred to the Pulmonary Branch, National Heart, Lung, and Blood Institute for evaluation of interstitial lung disease. From this group, patients were determined to have IPF if they fit the following criteria (14) (15) (16) .
Clinical. History of exertional breathlessness; no history of exposure to inorganic, organic, gaseous, physical, or pharmacologic agents known to cause pulmonary fibrosis; no history suggestive of an allergic pulmonary disorder; no history of chronic pulmonary infection; and no historical or physical evidence of left ventricular failure. All patients underwent fiberoptic bronchoscopy (B2F, Olympus Corporation of America, New Hyde Park, N. Y.) and were demonstrated to have normal airways within limits ofthe procedure.
Roentgenographic. The presence of a diffuse infiltrative pattern (reticular, reticulonodular, or ground glass) on a routine posterior-anterior chest film and no evidence of left ventricular disease.
Physiologic. Reduced lung volumes or reduced diffusing capacity or both; mild to moderate hypoxemia at rest which worsened with exercise, and a static volume-pressure curve consistent with fibrotic disease (see below for physiologic methods).
Morphologic. Lung biopsy showing varying degrees of alveolar septal fibrosis and inflammation with interstitial and intra-alveolar inflammatory cells (predominantly mononuclear cells, but often accompanied by neutrophils and eosinophils); no granuloma, no vasculitis, no evidence of inorganic material by polarized light microscopy, and negative cultures for bacteria and fungi.
Patients were included in the current study if they met all of the diagnostic criteria for IPF, and had no evidence of airways disease by standard criteria (forced expiratory volume in 1 s/forced vital capacity and airway resistance). In addition, they had to have had a recent lung biopsy demonstrating airways of <2 mm in diameter and be able to participate in measurement of at least two of three monitors of small airways (see below).
From the initial group of 150 patients, 50 had the diagnosis of IPF and 18 of these fit all of the criteria to be included in this study. Patients who were excluded from the study were done so largely because of failure to have a recent biopsy or because of advanced disease and inability to participate in physiologic studies. 15 had no evidence of a collagen vascular disease, two (M. C., V. J.) had rheumatoid arthritis, and one (0. N.) had an overlap connective tissue syndrome. Eight patients had open lung biopsy at our institution with physiologic testing performed within 2 wk before biopsy. The remaining 10 patients had lung biopsies performed at an outside institution with physiologic testing performed at our institution 3-18 mo (average 4 mo) after biopsy.
Airway morphology
Morphological observations were made by one of us (W. C. R.) without knowledge of the results of the physiological testing. All observations were made on surgical specimens fixed in formalin, processed in alcohols and xylene, imbedded in paraffin, sectioned at 6 ,m intervals, and then stained with hematoxylin and eosin. Serial sections were evaluated whenever possible. Airways of 2-mm diameter or less which had nearly perpendicular cuts were selected for evaluation. Each biopsy contained an average of 7.7±0.72 airways which were suitable for study.
The following histologic features of small airways were noted if present: peribronchiolar fibrosis, peribronchiolar inflammation, and bronchiolitis. In addition, the diameters of small airways were graded as to whether they were normal, narrowed, or dilated by the following criteria: (a) comparing the diameter of the bronchiolar lumen to the diameter of the lumen of the accompanying pulmonary artery (the bronchiolar lumen should be as large or larger than the lumen of the artery); (b) comparing the diameter of the bronchiolar lumen in the biopsy to the bronchiolar lumen of noninflated normal lung with comparable sized bronchioles and pulmonary arteries; and (c) comparing the thickness ofthe bronchiolar wall to the thickness of the wall of comparably sized airways of noninflated normal lungs. Changes in pulmonary artery diameter associated with pulmonary hypertension were quantitated to adjust lumen diameter to a normal size and prevent over estimation of airway diameter. If an airway was normal or dilated, but on serial section was shown to be narrowed at some point, it was graded as narrowed.
To facilitate comparison of morphologic and physiologic studies, an overall estimate of the diameter of the small airways in each biopsy was made using the following criteria: if 60% or more airways in the biopsy were narrowed, airways diameter was considered "narrowed," independent of status ofthe other airways; if70% or more ofthe airways in the biopsy were normal or dilated (i.e. 30% or less were narrowed), airways diameter was considered "not narrowed," independent of the status of the other airways. If 31-59% of the airways in the biopsy were narrowed, the morphologic data for that patient were not used for statistical comparison with the physiologic data.
Lung volumes, timed expiratory maneuver, and diffusing capacity Lung volumes, timed expiratory maneuver and diffusing capacity were measured on a computerized lung analyzer (Warren E. Collins, Inc., Braintree, Mass.). Vital capacity (VC), forced vital capacity, forced expiratory volume in 1 s, and inspiratory capacity were done in the standing position. Functional residual capacity (FRC) was done in the sitting 2All data will be presented as mean+SEM.
position utilizing a closed circuit helium equilibration technique (22) . Expiratory reserve volume was subtracted from FRC to obtain residual volume (RV) and VC was added to RV to obtain observed total lung capacity (TLC). Predicted values for VC, forced expiratory volume in 1 s, and forced expiratory volume in 1 s/forced vital capacity (FEV,%) were obtained from the data of Morris et al. (23) . Predicted FRC and RV were obtained from the normals of Goldman and Becklake (24) . Predicted TLC was obtained by adding predicted VC to predicted RV. The lower limit of lung volumes was considered to be -20% of the predicted value. The lower limit for FEV,% was considered to be equal to the predicted FEV,%-5% (25) .
Single-breath carbon monoxide diffusing capacity (DLCO) was performed by the method of Ogilvie et al. (26) . The program was modified so that alveolar volume was determined by a single-breath helium dilutional technique. Alveolar gas was quantitated after absorption of CO2; gas concentrations were then adjusted by 6% for CO2 removal (6% is the usual alveolar CO2 concentration). The results were compared to the predicted values of Gaensler and Wright (27 A minimum of three MEFV curves were performed at each sitting and most patients had four to six curves done during their evaluation. The two most reproducible curves with the best flow rates and volumes within ±+5% of VC (as quantitated by standard water spirometry) were accepted. Final MEFV curves were constructed from these data using the highest flow rates at all volumes.
The final MEFV data were analyzed by three methods: (a) with flow (liters/second) plotted against volume (observed VC); (b) with flow (liters/second) plotted against volume (percent observed TLC); and (c) with flow divided by observed TLC (liters/second per liter) plotted against volume (percent observed VC remaining). Because of the wide variation in lung volumes in the patient population, method c was found to be most useful; these data were compared to the normal values of Gelb et al. (29) .
Static compliance, dynamic compliance, and isovolume pressure-flow curves These data were obtained in the sitting position utilizing a wedge spirometer for quantitation of volume and flow rates.
Transpulmonary pressure (Po was measured as the difference between mouth and esophageal pressure utilizing a Sanborn 268-B differential strain gauge and carrier preamplifier (Hewlett-Packard Co.). Volume, flow, and PL signals were recorded on a Brush model 480, eight channel universal recorder (Gould, Inc.). The esophageal pressure signal was transmitted by a 10 cm, thin-walled, latex balloon (Young Rubber Co., Trenton, N.J.) positioned in the lower third of the esophagus by first passing it into the stomach and observing for a positive defection, then withdrawing the balloon approximately 10 cm so that the pressure signal was maximum and artifact free. Balloon volume was corrected by the methods of Milic-Emili et al. (30) or Lemen et al. (31) ; the latter technique was simpler and closely agrees with the former.
The wedge spirometer was calibrated electronically and checked manually utilizing a 1-liter syringe and a 0-10 liter/s flow meter. Using a sine wave generator, the frequency response of the spirometer was +5% at 6 cycles/s and flow was linear from 0.1 to 10 liters/s. The Sanborn 268-B differential strain gauge was linear between 0-100 cm H2O and had a frequency response which was ±+5% at 6 cycles/s. Evaluation of phase lag between signals of flow, volume, and esophageal balloon pressure was performed by inserting the balloon inside the wedge spirometer and applying a sine wave (using a 500-ml pump) to the system. These signals were in phase (<50 shift) up to 3 cycles/s.
A constant volume history was assured by having the patient hyperventilate and then inspire to TLC three times (32) . Static transpulmonary pressure (Pst) was measured at TLC and during deflation as the pressure difference between mouth and esophageal pressure with glottis open and flow being intemrpted by a solenoid-operated shutter.
Static volume-pressure curves were constructed utilizing a mean of four deflation maneuvers with 12-14 points per maneuver. NVolume was converted to body temperature and pressure saturated and required to be ±5% of V'C (as recorded on standard spirometry). Because of the marked variability of Pst below 50% observed TLC, static volume-pressure curves were constructed from TLC to 50% observed TLC. Volume was expressed both as a percentage of observed and predicted TLC and compared to the predicted data of Turner et al. (32) .
Data for generation of isovolume pressure-flow curves were obtained by having the patient exhale from TLC to RV at varying efforts from maximum flow to 0.5 liter/s. From simultaneously recorded flow, volume, and PL data, isovolume pressure-flow curves were constructed at 70, 50, and 30% VC according to the method of Hyatt et al. (33) .
Dynamic compliance (Cdyn) was measured by having the patient first hyperventilate, inspire to TLC three times, and then breathe at a constant tidal volume at increasing frequencies up to 100 breaths/min. Flow, volume, and PL were simultaneously recorded while a constant resting end expiratory point and resting end inspiratory point were maintained by having the patient observe his breathing pattern (volume) on a time base oscilloscope. For each frequency, Cdyn was calculated by dividing the volume change by the change in pressure at points of zero flow over 10 or more breaths and Small Airwcays in Idiopathic Ptulmonary Fibrosis 597
averaging the results. Cdyn was expressed as a percentage ofinitial Cdyn (Cdyn/initial Cdyn) and plotted against respiratory frequency. A frequency dependent decrease in Cdyn/ initial Cdyn of > 20% was considered to be abnormal (34, 35) .
To determine the effect of bronchodilators on Cdyn, these maneuvers were repeated immediately after 0.5 ml of 1% isoetherine was administered as an aerosol inhalant.
Maximum flow-static recoil relationship
The relafionship between maximum flow and static recoil (MFSR) was determined by plotting maximum expiratory flow (Vmax; obtained from the MEFV curve from 80 to 50% observed TLC) against Pst (derived from the static volume-pressure curve) at the same lung volumes (36) . These data were also plotted utilizing Vmax and Pst expressed as percentage of predicted lung volume. Predicted MFSR curves were obtained by plotting Vmax predicted by the data of Cherniack and Raber (37) against Pst at the same lung volume predicted by the data of Turner et al. (32) . The prediction curves were grouped by age range from 25 to 45 yr and greater than 45 yr. These curves compare favorably to the normal curves of Mead et al. (36) and Ostrow and Cherniack. (38) .
Statistical analysis of data
Three statistical methods were used for data analysis: Spearman rank correlafion, two-tailed Student's t-test, and Fisher's exact test. To facilitate discussion of the analysis, the data were grouped as follows: "clinical data" include age, sex, duration of symptoms, smoking history, and drug therapy; "standard physiologic studies" include VC, FRC, TLC, RV/TLC, and DLCO; "physiologic monitors of small airways" include Cdyn, MEFV curves, and MFSR curves; and "overall estimate of small airways diameter" refers to the rating ("narrowed" or "not narrowed") given to each biopsy as defined by the criteria listed above.
The 
RESULTS
Clinical data. The 18 study patients ranged in age from 27 to 67 yr, 12 were male and 6 were female (Table I) . Six patients never smoked; an additional three were light cigarette smokers (<10 pack yr) and one was a cigar smoker. The remaining eight patients were either moderate (10-25 pack yr) or heavy smokers (>25 pack yr) and none had a history of sputum production. The duration of symptoms (before study at National Institutes of Health) ranged from 0.5 to 10 yr, but was c 2 yr in all but one patient (W. L.). Eight patients were taking prednisone at the time of evaluation; one was taking phenylbutazone, and none was taking sympathomimetic agents or xanthines. Morphologic evaluation of small airways in IPF. A total of 138 small airways were suitable for evaluation in the lung biopsies of the 18 patients (Table II) . The most frequently observed morphologic abnormality was peribronchiolar fibrosis, either alone or together with peribronchiolar inflammation and bronchiolitis (Fig. 1) . No airway was seen with bronchiolitis alone. Only one patient (W. L. S.) had completely normal airways.
Each biopsy was graded an average of three times. Using the grading criteria for airway diameter, the mean intraobserver coefficient of variation was 9.1.
±0.2%; the mean interobserver error was 10%. Of the total airways evaluated, 19% were of normal diameter, 27% were dilated, and 54% were narrowed (Table II) . The dominant histologic abnormality accompanying narrowed airways was peribronchiolar fibrosis with infolding and stenosis ( Fig. 1 B) ; seen less frequently was peribronchiolar fibrosis or inflammation and bronchiolitis (Fig. 1 C) . The presence of histologic abnormalities of small airways did not necessarily mean the airway would be narrowed; peribronchiolar inflammation and peribronchiolar fibrosis were associated with airways that were of normal diameter (Fig. 1 A) or dilated (Fig. 1 D) .
Using the criteria listed in Methods, overall estimates of small airways diameter revealed that 12 of the 18 patients (67%) had "narrowed" airways (i.e. in these patients, 60% or more of the small airways evaluated were narrowed) and the remaining 6 patients (33%) had "not narrowed" airways (i.e. in these patients, 70% or more of the airways evaluated were normal or dilated).
Standard physiologic studies and routine monitors of airways. The lung volumes were variable in the 18 patients with IPF, but the mean predicted values were significantly reduced (Table III) . Although patients with histologically proven IPF are generally considered to have reduced volumes, one (E. B.) had a TLC within the normal range. Likewise, although almost all of the patients had a reduced DLCO (mean 52.7% predicted), one patient (B. T.) had a DLCO within the normal range. Thus, all of the patients had either a reduced TLC or DLCO, and 89% had both. The average RV/TLC was 31.8%; 10 patients had normal RV/TLC (<30% observed). 598 (Fig. 4) . Three patients (G. F., P R., and B. T.) exhibited Cdyn which was less frequency dependent after nebulized bronchodilators. In no case did the use of bronchodilators cause the Cdyn to become independent of frequency (data not shown).
Nine patients had abnormal MEFV curves with reduced flows at low lung volumes and nine had normal to increased flows at all lung volumes (Fig. 5) Pst with a shift of the MFSR curve to the right of the normal range. The remaining 11 patients had normal to increased flow rates for a given P,t (Fig. 6 ). Both methods of analysis (see Methods) gave comparable results.
Obtaining meaningful MEFV and MFSR curves depends upon achieving maximum flow. To verify that maximum flow was achieved in these studies, isovolume pressure-flow curves were constructed. 15 with the overall estimate of small airways diameter, 11 tion of symptoms, drugs (on or off anti-inflammatory had "narrowed" airways and 6 had "not narrowed" medications), lung volumes (VC, FRC, TLC), or diffusairways. The overall estimate of small airway diameter ing capacity (Tables IV, V) Cdyn was the most sensitive predictor of the diameter of small airways (P = 0.001, Table VI); 9 of the 10 patients in whom airways were narrowed had frequency-dependent Cdyn and all 6 patients with not narrowed airways had normal Cdyn. Only one patient who had narrowed airways exhibited normal Cdyn; in no case was Cdyn frequency dependent in a patient who had airways of normal diameter.
The next most sensitive predictor of small airways diameter was the MEFV curve (P = 0.009, Table   VI ). 8 of the 11 patients in whom airways were narrowed had abnormal MEFV curves, whereas all 6 patients in whom airways were considered not narrowed had normal MEFV curves. However, three patients with narrowed small airways had normal MEFV curves. Like Cdyn, in no case was the MEFV curve abnormal in a patient who had airways that were considered not narrowed.
The third physiologic monitor of small airways, the MFSR relationship, was abnormal in 7 of the 11 patients with narrowed airways, and normal in all 6 patients with airways that were not narrowed (Table  VI) . However, four patients with narrowed airways had MFSR curves within the normal range. Like the other monitors of small airways, the MFSR curve was never Table III. abnormal in a patient whose airways were considered not narrowed. Even so, the lack of a significant association between the MFSR curve and the overall estimate of small airways diameter suggested that the MFSR curve is not as sensitive as Cdyn or the MEFV curve in detecting narrowed small airways in patients with IPF. There was no significant correlation between age, sex, smoking history, duration of symptoms, VC, FRC, RV/TLC, DLCO, and the physiologic monitors of small airways (Table VII) . However, there was a significant negative correlation between TLC and Cdyn and between TLC and the MEFV curves; patients with smaller total lulng capacities tended to have normal Cdyn and normal MEFV curves, whereas those with larger total lung capacities tended to have frequencydependent Cdyn and abnormal MEFV curves.
Although comparison of the physiologic data with the overall estimate of small airways diameter suggests that RV/TLC (Tables IV, V) , Cdyn, and MEFV curves (Table VI) can predict narrowed small airways, only the results of the MEFV curves correlated with the results of Cdyn (the most sensitive predictor of the overall estimate of small airways diameter, Table VIII) , suggesting a divergence in the physiologic ftinctions monitored by some of these tests.
DISCUSSION
Althouigh narrowing and stenosis of small airways were noted in the original description of IPF by Hamman and Rich (1), subsequent morphologic reports have largely concentrated on the alveoli and alveolar interstitium (3, 4, 8-10, 13); perhaps because the significance of small airways abnormalities in the pathophysiology of some chronic pulmonary disorders has only recently been recognized (42, 43) . The data presented in this investigation indicate that morphologic and physiologic abnormalities of small airways are present 1"Data from Table III. in IPF. The patients studied were representative of patients with IPF; the duration of symptoms and lung biopsy were typical of patients in mid-course (3-13). None had morphologic flndings consistent with "end stage" lung (44) . Morphologic evaluation of small airways in IPF.
Only one patient had completely normal airways; in the remainder, the majority of the small airways had Tables I, II) . Thus, even though bronchiolar fibrosis and inflammation have been described in smokers (45) (46) (47) , the lack of correlation of airway abnormalities and smoking history (Table IV , P = 0.836)
suggests smoking was not the causative agent in these patients with IPF. In addition, there was no evidence that the airway abnormalities were secondary to intercurrent infection, because all bacterial, mycobacterial, fungal, and viral cultures of open lung biopsies done at our institution were negative. Some degree of bronchiolectasis was present in approximately one-fourth of all airways evaluated. Although there is no correlation between the morphologic assessment of the severity of disease and airway diameter, it is our impression that small airways in IPF progress through stages beginning with peribronchiolar inflammation leading to peribronchiolar fibrosis. With progressive fibrosis, it is probable that some air-606 J. D. Fulmer, W. C. Roberts, E R. von Gal, and R. G. Crystal ways stenose, whereas others become distorted and ectatic (44) . However, this would be difficult to prove. Even though almost all of the patients had morphologic abnormalities of small airways, these do not necessarily imply airways dysfunction. If intrinsic small airways abnormalities contribute significantly to airways dysfunction, the feature which should be compared to the physiologic studies is airway diameter (e.g. narrowed or not narrowed). 12 of the 18 patients had an overall estimate of small airways diameter of narrowed; the morphologic data, therefore, suggest that these patients have physiologic alterations consistent with obstruction of small airways.
It may be argued that biopsy specimens are not representative of the disease and that multiple samples, available only at autopsy, are necessary to fully evaluate IPF; or that biopsy specimens present special problems in the evaluation of airways diameter because it is not possible to "physiologically" inflate and fix an open lung biopsy as can be done with postmortem lung. However, it is critical that evaluation of small airways in IPF be done with biopsy (rather than postmortem) material because: (a) patients with IPF often die from a generalized pulmonary infection, a process which in itself may alter the morphology and diameter of small airways; (b) those who die without respiratory infection usually have "end-stage" lung, in which the disease is too far advanced to allow for rational morphologic analysis; and (c) to compare airway morphology with airway function (i.e. with physiologic studies), it is necessary to make the interval between the two as short as possible; a situation which is impossible when relying on postmortem lung.
Thus, to study small airway morphology in IPF in mid-course, it is mandatory that only biopsy material be used. To attempt to minimize errors in estimating airway diameter, detailed diameter grading was not attempted, only categories of narrowed, normal, or dilated were used. In addition, three independent criteria were used to estimate airway diameter; all done without knowledge of the physiologic data. Each method of diameter estimate gave similar results. In addition, to attempt to provide "representative" biopsies, the specimens were taken in areas appearing "average" on the chest roentgenogram.
Physiologic evaluation of small airways in IPF. None of the study patients had evidence of increased resistance to airflow by standard monitors of airway function (FEV,%, Raw). However, a significant number had abnormalities in physiologic tests considered to be monitors of small airways function. 59% had frequency-dependent Cydn (a decrease in Cdyn/initial Cdyn of greater than 20% with increasing respiratory rates). The remaining patients had normal Cdyn (a change of no more than 20% of Cdyn/initial Cdyn at increasing respiratory rates). In addition, 50% of the patients had abnormal MEFV curves and 39% had abnormal MEFV curves.
When the Cdyn data were plotted as percent of static compliance (Cstat) as described by Woolcock et al. (56) , five of the seven patients (W. H., W. L. S., 0. N., N. C., J. C. S.) with normal Cdyn (Fig. 3, group A. ) had Cdyn/Cstat of < 80% at initial breathing frequencies (data not shown). This subgroup of patients did not, however, exhibit a progressive fall in Cdyn with increasing respiratory rates regardless of the method of analysis (Cdyn/initial Cdyn or Cdyn/Cstat). Four of these patients have been restudied at 3-6 mo intervals and exhibit identical reductions in Cdyn/Cstat at initial breathing frequencies without frequency dependence. Reduced Cdyn/Cstat at initial respiratory rates have been previously noted in fibrotic lung disease (49, 50) . The reason for this is not clear, although alterations in surface forces which result in increased hysteresis are possible (49) . In our patients, analysis of physiologic and morphologic data did not reveal significant differences between this subgroup of patients compared to those whose Cdyn/Cstat were > 80% at initial respiratory rates. The former did, however, tend to have more severe fibrosis.
Other physiologic studies have suggested that patients with IPF have small airways abnormalities. In a study ofairway function in pulmonary fibrosis, Ostrow and Cherniack (38) included patients with "cryptogenic fibrosing alveolitis" whose physiologic features were similar to our patients. Like our study group, their patients had normal airway function by standard criteria, yet a significant number had physiologic evidence of increased resistance to airflow in small airways. A similar study by Yernalt et al. (49) also demonstrated that many of these patients have evidence of increased small airways resistance. In contrast, Schofield et al. (51) measured upstream conductance in patients with fibrotic lung disease (three with IPF), and found that these patients had normal upstream conductance. However, it is likely that those patients fall into the group of our patients (61%) that also had normal MFSR curves.
Recent studies have suggested that closing volume and closing capacity might be useful monitors of small airways in fibrotic lung disease (52, 53 Even though 39% of the patients had abnormal MFSR curves, these data did not correlate with the morphologic assessment ofairway narrowing (P = 0.10, Table VI ). This lack of significant correlation occurred because although patients with not narrowed airways always had a normal MFSR curve, 4 of the 11 patients with narrowed airways also had normal MFSR studies. Thus, of the three physiologic methods (Cdyn, MEFV, MFSR) used in this study to test small airway function, the MFSR curve is the least sensitive. This may be due to the complexity of the volume-pressure curve in this disease, particularly at low lung volumes. Although almost all of our patients had increased elastic recoil near TLC, some had reduced recoil near FRC ( Fig. 2  and 3 ). Similar volume-pressure curves were observed by Ostrow and Cherniack (38) (6, 7, 16 (Table VIII) . These results are similar to that found by Martin et 
